Global Information
회사소개 | 문의 | 비교리스트

조직은행 시장 : 규모, 점유율, 전망, 기회 분석(2018-2026년)

Tissue Banking Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

리서치사 Coherent Market Insights
발행일 2019년 05월 상품 코드 865077
페이지 정보 영문
가격
US $ 4,500 ₩ 5,431,000 PPT Turned PDF (Single User License)
US $ 7,000 ₩ 8,449,000 PPT Turned PDF (Multi-user License)
US $ 10,000 ₩ 12,070,000 PPT Turned PDF (Enterprise User License)


조직은행 시장 : 규모, 점유율, 전망, 기회 분석(2018-2026년) Tissue Banking Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

외과 수술에서 동종 이식의 수요, 고관절 치환술에서 골이식편의 수요, 대퇴골 골두 동종 이식의 수요, 화상 환자 증가 등에 의해 조직은행 시장 성장이 촉진되고 있습니다.

세계의 조직은행(Tissue Banking) 시장을 조사했으며, 시장 개요, 제품·조직 종류·지역별 시장 규모 추정과 예측, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 조사 목적과 가정

  • 조사 목적
  • 가정
  • 약어

제2장 시장 개요

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
    • 시장 정보 : 제품별
    • 시장 정보 : 조직 종류별
    • 시장 정보 : 지역별
  • COM(Coherent Opportunity Map)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
  • 영향 분석
  • 시장 동향
  • 주요 개발
  • 기술 진보
  • 공급망 분석
  • 규제 상황
  • PEST 분석

제4장 세계의 조직은행 시장 : 제품별

  • 서론
  • 매체 및 소모품
  • 장비

제5장 세계의 조직은행 시장 : 조직 종류별

  • 서론
  • 뇌 및 척수
  • 각막
  • 심장 판막
  • 기타

제6장 세계의 조직은행 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 중남미
  • 아프리카
  • 중동

제7장 경쟁 상황

  • 히트맵 분석
  • 기업 개요
    • AbD Serotec
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.
  • 애널리스트의 의견

제8장 섹션

  • 참고 문헌
  • 조사 방법
  • Cohrenet Market Insights 소개
KSM 19.06.21

Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility.

Market Dynamics

Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.

Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2017, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.

Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.

Key features of the study:

  • This report provides in-depth analysis of the tissue banking market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global tissue banking market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological upgradation, market expansion, and marketing tactics
  • The global tissue banking market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for tissue banking market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Tissue Banking Market, By Product:
  • Media and Consumables
  • Equipment
    • Cryopreservation Equipment
    • Quality Control Equipment
    • Thawing equipment
    • Others
  • Global Tissue Banking Market, By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Global Tissue Banking Market, By Region:
  • North America
    • By Country:
  • U.S.
  • Canada
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Europe
    • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Asia Pacific
    • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Latin America
    • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Middle East
    • By Country:
  • GCC
  • Israel
  • Rest of Middle East
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Africa
    • By Country:
  • South Africa
  • Central Africa
  • North Africa
    • By Product:
  • Media and Consumables
  • Equipment
  • Cryopreservation Equipment
  • Quality Control Equipment
  • Thawing equipment
  • Others
    • By Tissue Type:
  • Bone
  • Brain & Spinal Cord
  • Cornea
  • Heart Valves
  • Skin
  • Others
  • Company Profiles
  • AbD Serotec*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • AMS Biotechnology Limited
  • BioLife Solutions, Inc.
  • Beckman Coulter, Inc.
  • BioCision LLC
  • BioStorage Technologies, Inc.
  • Custom BioGenic Systems
  • Eppendorf AG
  • EMD Millipore Corporation
  • Fisher BioServices, Inc.
  • Genzyme Corporation
  • Hamilton Company
  • Merck KGaA
  • PHC Corporation
  • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Tissue Type
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technological Advancements
  • Supply Chain Analysis
  • Regulatory Landscape
  • PEST Analysis

4. Global Tissue Banking Market, By Product, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Media and Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
    • Cryopreservation Equipment
    • Quality Control Equipment
    • Thawing Equipment
    • Others

5. Global Tissue Banking Market, By Tissue Type, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Bone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Brain and Spinal Cord
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Cornea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Heart Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Tissue Banking Market, By Region, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2016 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Product, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Tissue Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • AbD Serotec
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • AMS Biotechnology Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioLife Solutions, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Beckman Coulter, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioCision LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • BioStorage Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Custom BioGenic Systems
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Eppendorf AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • EMD Millipore Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fisher BioServices, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Genzyme Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Hamilton Company
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Merck KGaA
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • PHC Corporation
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Back to Top
전화 문의
F A Q